Hostname: page-component-74656f9884-rngvg Total loading time: 0 Render date: 2026-11-06T10:46:01.999Z Has data issue: false hasContentIssue false

Crystal structure of nilotinib, C28H22F3N7O

Published online by Cambridge University Press:  14 August 2015

James A. Kaduk*
Affiliation:
Illinois Institute of Technology, 3101 S. Dearborn St., Chicago, Illinois 60616
Kai Zhong
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, Pennsylvania 19073-3273
Amy M. Gindhart
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, Pennsylvania 19073-3273
Thomas N. Blanton
Affiliation:
ICDD, 12 Campus Blvd., Newtown Square, Pennsylvania 19073-3273
*
a) Author to whom correspondence should be addressed. Electronic mail: kaduk@polycrystallography.com

Abstract

The crystal structure of nilotinib has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Nilotinib crystallizes in space group P1 (#1) with a = 4.518 14(3), b = 10.638 01(5), c = 13.703 77(8) Å, α = 68.8607(4), β = 82.1486(5), γ = 84.1978(5)°, V = 607.62(1) Å3, and Z = 1. The most prominent feature of the structure is two strong hydrogen bonds. These form chains with a graph set C1,1(13); the chains run along [111]. Several weak C–H···O hydrogen bonds also contribute to the packing. The powder pattern has been submitted to ICDD for inclusion in future releases of the Powder Diffraction File™.

Information

Type
Technical Articles
Copyright
Copyright © International Centre for Diffraction Data 2015 
Figure 0

Figure 1. The molecular structure of nilotinib.

Figure 1

Figure 2. (Color online) The Rietveld plot for the refinement of nilotinib. The red crosses represent the observed data points, and the green line is the calculated pattern. The magenta curve is the difference pattern, plotted at the same vertical scales as the other patterns. The vertical scale has been multiplied by a factor of 5 for 2θ > 7.2° and by a factor of 20 for 2θ > 12.8°.

Figure 2

Figure 3. (Color online) Comparison of the refined and optimized structures of nilotinib. The Rietveld refined structure is in red and the DFT-optimized structure is in blue.

Figure 3

Figure 4. (Color online) The molecular structure of nilotinib, with the atom numbering. The atoms are represented by 50% probability spheroids.

Figure 4

Figure 5. (Color online) (a) The crystal structure of nilotinib, viewed down the a-axis. (b) A view down the b-axis, showing the parallel stacking of aromatic rings.

Figure 5

Table I. Rietveld refined crystal structure of nilotinib.

Figure 6

Table II. DFT (CRYSTAL09) optimized crystal structure of nilotinib.

Figure 7

Table III. Hydrogen bonds in nilotinib.

Figure 8

Figure 6. (Color online) The Hirshfeld surface of nilotinib. Intermolecular contacts longer than the sums of the van der Waals radii are colored blue, and contacts shorter than the sums of the radii are colored red. Contacts equal to the sums of radii are white.

Supplementary material: File

Kaduk supplementary material

Kaduk supplementary material 1

Download Kaduk supplementary material(File)
File 2.7 MB
Supplementary material: File

Kaduk supplementary material

Kaduk supplementary material 2

Download Kaduk supplementary material(File)
File 8.4 KB